Lb Pharmaceuticals LBRX
NASDAQ LBRX
$37.28 -1.10 (-2.87%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Free Cash Flow (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) posted Free Cash Flow of -$37.98 million for Q2 2026, compared with -$5.6 million a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) Free Cash Flow (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Free Cash Flow at Lb Pharmaceuticals was -$82.83 million; for FY2025, it was -$35.26 million.

  • In prior years, Lb Pharmaceuticals' Free Cash Flow was -$53.82 million in FY2024.
  • According to Business Quant data, Free Cash Flow for the three prior quarters was -$23.33 million (Q1 2026), -$18.14 million (Q4 2025) and -$3.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 Lb Pharmaceuticals 1.10 Bn 1.10 Bn - -37.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.98 Mn
Mar 31, 2026 -23.33 Mn
Dec 31, 2025 -18.14 Mn
Sep 30, 2025 -3.37 Mn
Jun 30, 2025 -5.60 Mn
Mar 31, 2025 -8.15 Mn
Dec 31, 2024 -5.90 Mn
API Access

Lb Pharmaceuticals Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=LBRX&period=max&api_key=YOUR_API_KEY